Results 51 to 60 of about 5,906 (249)
Archives of Disease in Childhood, 2023 Background Burosumab, an antifibroblast growth factor 23 monoclonal antibody, improves rickets severity, symptoms and growth in children with X-linked hypophosphataemia (XLH) followed up to 64 weeks in clinical trials.
E. Walker +5 more
semanticscholar +1 more source
Dyspnea and Generalized Paresthesias Due to a Rare Metabolic Disorder: Severe Hypophosphatemia
Medicine Science, 2016 We present a patient with severe hypophosphatemia related hypoxic respiratory failure resolving with phosphate replacement. [Med-Science 2016; 5(2.000): 747-50]
Seyit Ahmet Uslu +3 more
doaj +1 more source
A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection [PDF]
, 2014 A number of antiviral agents used against Human Immunodeficiency Virus (HIV) infection and hepatitis B virus (HBV) mono or co-infection have been associated with real nephrotoxicity (including tenofovir disoproxil fumarate (TDF), atazanavir, indinavir ...
Abbas, R. +9 more
core +3 more sources
Isolated hypophosphataemia as an early marker of primary hyperparathyroidism
Endocrinology, Diabetes & Metabolism Case Reports, 2021 Primary hyperparathyroidism (PHPT) is a disease caused by overactive parathyroid glands with consequent hypercalcaemia. The main cause in 85–90% of the cases is the presence of a solitary parathyroid adenoma.
John Alexander, Dinesh Nagi
doaj +1 more source
Hypophosphataemia in anorexia nervosa [PDF]
Postgraduate Medical Journal, 2001 The prevalence, causes, and consequences of hypophosphataemia in the clinical treatment of various diseases are described in the literature, but are not so seriously regarded as a severe electrolytical disturbance.1-3 The clinical conditions when hypophosphataemia should be suspected are listed in fig 1.
openaire +2 more sources
Internal medicine journal (Print), 2023 Coadministration of ferric carboxymaltose and denosumab may cause hypocalcaemia and hypophosphataemia; however, this interaction is not well‐described in the literature and has typically been described in patients with chronic kidney disease (CKD).
Jaidyn Muhandiramge +3 more
semanticscholar +1 more source
Advances in Therapy, 2023 Introduction X-linked hypophosphataemia (XLH) is a rare, genetic renal phosphate-wasting disease, resulting from excess fibroblast growth factor 23 (FGF23) activity, which has a progressive and profound impact on patients throughout life.
T. Kubota +9 more
semanticscholar +1 more source
Drug-induced metabolic acidosis [PDF]
, 2017 Summary: Drug causes of metabolic acidosis are numerous and their mechanisms are diverse. Broadly, they can cause metabolic acidosis with either a normal anion gap (e.g. drug-induced renal tubular acidosis) or an elevated anion gap (e.g.
Boton +33 more
core +1 more source
Tumour-induced osteomalacia due to phosphaturic mesenchymal tumour of the ethmoid
Journal of Clinical and Scientific Research, 2017 Tumour-induced hypophosphatemic osteomalacia is often due to mesenchymal tumours. Surgical resection of tumour gives complete relief. We present the case of a 66-year-old male who sustained fracture of the hip after a trivial fall.
Honey Ashok +7 more
doaj +1 more source
Anales de Pediatría, 2021 Resumen: Introducción: La nutrición parenteral agresiva con aportes energéticos y proteicos altos se utiliza para mejorar el crecimiento y el neurodesarrollo en recién nacidos prematuros de muy bajo peso. No obstante, hallazgos recientes sugieren que su
Carlos Javier Parramón-Teixidó +6 more
doaj +1 more source